Larson Financial Group »

Tvardi Therapeutics shares owned by Larson Financial Group

Quarter-by-quarter ownership of Tvardi Therapeutics (TVRD) shares owned by Larson Financial Group from 13F filings

Historical chart of Larson Financial Group investment in Tvardi Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tvardi Therapeutics held by Larson Financial Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tvardi Therapeutics by Larson Financial Group

Quarter filed Position value Share count Share price at filing
2025-12-31 $9 2 4.50

More positions owned by Larson Financial Group

Spdr Series Trust State Street Spd (SPYM)
Apple (AAPL)
Wisdomtree Tr Us Qtly Div Grt (DGRW)
American Centy Etf Tr Us Quality Grow (QGRO)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Mid Cap Etf (VO)
Capital Group Global Equity SHS (CGGE)
Franklin Templeton Etf Tr Us Mid Cp Mltfct (FLQM)
Invesco Exchange Traded Fd T Rafi Us 1000 Etf (PRF)
Microsoft Corporation (MSFT)
Ishares Tr Msci Intl Qualty (IQLT)
J P Morgan Exchange Traded F Active Bond Etf (JBND)
Applied Materials (AMAT)
Fidelity Merrimack Str Tr Total Bd Etf (FBND)
Pgim Etf Tr Active Aggregate (PAB)

View all positions for Larson Financial Group

Top funds holding Tvardi Therapeutics

Slate Path Capital
Vanguard Group
BlackRock
American Financial Group
Geode Capital Management
State Street Corporation
Renaissance Technologies
FMR
Duncan Williams Asset Management
Squarepoint Ops
Northern Trust
Jane Street
Farallon Capital Management
UBS Group
Goldman Sachs Group

View all funds holding Tvardi Therapeutics